Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru
about
Anthelmintics for people with neurocysticercosisAnthelmintics for people with neurocysticercosisTaenia solium cysticercosisProposed diagnostic criteria for neurocysticercosisA systematic review of taeniasis, cysticercosis and trichinellosis in VietnamAccuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa.Exposure to multiple parasites is associated with the prevalence of active convulsive epilepsy in sub-Saharan AfricaSeroprevalence of cysticercosis in children and young adults living in a helminth endemic community in leyte, the Philippines.Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosisPediatric neurocysticercosis: usefulness of antibody response in cysticidal treatment follow-up.Human neurocysticercosis: comparison of different diagnostic tests using cerebrospinal fluid.A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in PeruSerologic diagnosis of human Taenia solium cysticercosis by using recombinant and synthetic antigens in QuickELISA™.Parasite antigen in serum predicts the presence of viable brain parasites in patients with apparently calcified cysticercosis only.Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departmentsEpilepsy and neurocysticercosis in sub-Saharan Africa.Parasitic infections and myositis.Immunological and molecular diagnosis of cysticercosis.Diagnostic criteria for neurocysticercosis, revisited.Neurocysticercosis: A disease of neglect.Seroconversion of neurocysticercosis occurring after anti-helminthic treatment.Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group.Comparative Study of Paired Serum and Cerebrospinal Fluid Samples from Neurocysticercosis Patients for the Detection of Specific Antibody to Taenia solium Immunodiagnostic Antigen.Neurocysticercosis: unraveling the nature of the single cysticercal granuloma.Comparative profile of circulating antigenic peptides in CSF, serum & urine from patients with neurocysticercosis diagnosed by immunoblotting.Pediatric neurocysticercosis: current challenges and future prospects.The role of the irritative zone and of the number and distribution of calcifications in the severity of epilepsy associated with intracranial calcifications.Neurocysticercosis: is serology useful in the absence of brain imaging?Pediatric Neurocysticercosis.Inflammation is a key risk factor for persistent seizures in neurocysticercosis.Laboratory Diagnosis of Neurocysticercosis (Taenia solium)Crude antigen from Taenia crassiceps cysticercus used as heterologous antigen in ELISA and in EITB for neurocysticercosis diagnosis of patients from Paraná-BrazilAntibody Banding Patterns of the Enzyme-Linked Immunoelectrotransfer Blot and Brain Imaging Findings in Patients With Neurocysticercosis
P2860
Q24236593-8FBEF08E-BE1D-4544-A880-EF08E041B8B8Q24240646-F220596D-BFAD-4E80-803C-5CB374859982Q24630431-D4C8440A-483C-47E2-9BB4-851CF40859EEQ28345027-D457FC54-6D63-485F-B6C3-8566BAD27F98Q30235183-EE7D582C-6AA0-412A-B7EB-8556D7572E70Q30975304-200A4D6E-CC3D-42BF-9275-EDF7D586F8FEQ33685560-D108BB54-4FA3-432D-87A6-89346CDE9751Q33757894-1FFF2F0F-A44E-411C-946B-F3587045A200Q33763145-DA1E413B-865E-4D6A-85A9-AB6B8A2D49B5Q34151387-59CE99A7-9754-4D7D-98E1-1DCA5407D1BBQ34487432-C1730EE9-A3E7-48A1-BD03-A6C5E0357EADQ34513099-63ACA786-107B-4871-A56F-B52E49668ED7Q34707819-004E763B-69BA-4FDB-A49D-735E076C72FDQ37151516-D701DE3E-CBAD-4EAF-BA3D-EF804E9D4D68Q37334367-B3D9CE35-05C8-4F47-AAF3-D4923C0E470CQ37633387-04CCD70D-2AB5-4006-AE06-A66EE730CFB5Q37924643-0BD527AC-7594-4D1E-84E8-A6D0BBF3A72EQ38069635-D91CC30E-247D-4650-90CE-F840831F80E6Q38069636-13E272A5-7E03-4018-AFB4-3E2C3D30EBB4Q38182595-C445BE82-3DB6-4FCC-9DEF-751D83BDFD0DQ38977301-2A4C512A-E08B-40B1-9798-6EBEE7DAE422Q40235042-50F82F86-87AC-4716-B72F-6D4B81DB3430Q40920300-FAFF6418-0575-4255-A584-955BC1D010F0Q42139321-4A26548D-2E51-4A8A-A054-4D13AF389B1DQ46874384-049875A9-CCFE-4C2C-957C-8911B9A10793Q47699048-FDFB518F-B55C-4936-A9E8-EC53F90C291BQ48311277-28AA9492-452A-449F-97A6-D98FD598CA41Q48436319-AC0A40AF-F2E7-44A3-B1FF-4034408E58DDQ50001460-01F28AA8-46B3-41EA-AA0B-7BD4515A82EFQ55216162-7A5D8E6C-FC6E-4891-9B07-C7D3F4756510Q56340364-58ACEF42-7DB7-49C5-8FD5-350932D0E5F7Q57674143-63F2B762-11A6-4167-A594-067BD82E4B6BQ59093024-574A98E7-FD82-4423-8C43-B1F14F0D7525
P2860
Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Serologic evolution of neurocy ...... cercosis Working Group in Peru
@ast
Serologic evolution of neurocy ...... cercosis Working Group in Peru
@en
Serologic evolution of neurocy ...... cercosis Working Group in Peru
@nl
type
label
Serologic evolution of neurocy ...... cercosis Working Group in Peru
@ast
Serologic evolution of neurocy ...... cercosis Working Group in Peru
@en
Serologic evolution of neurocy ...... cercosis Working Group in Peru
@nl
prefLabel
Serologic evolution of neurocy ...... cercosis Working Group in Peru
@ast
Serologic evolution of neurocy ...... cercosis Working Group in Peru
@en
Serologic evolution of neurocy ...... cercosis Working Group in Peru
@nl
P2093
P2860
P356
P1476
Serologic evolution of neurocy ...... cercosis Working Group in Peru
@en
P2093
A E Gonzalez
H H Garcia
M Catacora
M Verastegui
R H Gilman
P2860
P304
P356
10.1093/INFDIS/175.2.486
P407
P577
1997-02-01T00:00:00Z